February 14th 2025
Cell and gene therapies can be life-changing for patients with certain conditions, but the process of receiving them poses barriers for patients and caregivers that require multistakeholder solutions, according to a white paper from the National Pharmaceutical Council.
Small but Nimble: Measures Taken to Face the COVID-19 Pandemic in Small French Military Hospitals
April 8th 2021Prioritization, interunit collaboration, esprit de corps, and health workers’ adaptability are key factors in providing a coherent response to the coronavirus disease 2019 pandemic.
Read More
Assessing Nutritional Risk Can Predict PAH Prognosis at First Hospitalization
April 6th 2021Adjunct nutritional therapies may be a simple way to improve the prognosis for patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension who are hospitalized.
Read More
Idiopathic Hypersomnia Campaign Seeks to Spread Awareness, Empower Patients
April 6th 2021A recently launched campaign by Jazz Pharmaceuticals and the Hypersomnia Foundation spotlights a lack of knowledge on idiopathic hypersomnia, as well as how care teams can optimally screen for symptoms and care for patients with the debilitating sleep disorder.
Read More
National Alliance Purchaser Survey Highlights Transition to Stabilized Business, Value-Based Care
April 1st 2021A survey of employer and purchaser members of the National Alliance of Healthcare Purchaser Coalitions found that over half expect a transition to a more stabilized business environment by the third quarter of this year, as well as increased benefit offerings on mental health access and virtual care delivery.
Read More
Leveraging Health Data and AI to Predict COVID-19 Hotspots
March 30th 2021Early on in the pandemic, Cotiviti developed a COVID-19 tracker map that accurately predicts where in the United States new COVID-19 outbreaks would occur. Nicole Neumarker, of Cotiviti, provides insight into what impact this technology could have in the future.
Listen
The Pfizer and Moderna COVID-19 vaccines were shown to be 90% effective in preventing infection in a real-world setting; Biden administration urges states to pause reopening plans amid signs of COVID-19 surge; a lawsuit seeks to end the requirement that preventive services be provided free of charge to Americans.
Read More
Workforce Development Implications for Health Care Systems During COVID-19 and Beyond
March 28th 2021Investing further in the development of health care staff in often overlooked aspects, such as digital technology and business acumen, can lead to incremental differences in engagement and productivity.
Watch
Hinge Health: Musculoskeletal Costs Doubled in Past Decade With No Benefit in Patient Outcomes
March 26th 2021Hinge Health’s State of MSK Report 2021 found that although patient outcomes remained stagnant in the past decade, cost for musculoskeletal care doubled with services provided in emergency rooms and outpatient/inpatient facilities associated with significantly increased spend.
Read More
Making Precision Medicine in Parkinson Disease a Reality: A Look at Challenges, Opportunities
March 26th 2021How are researchers leveraging what is currently known about the pathogenesis and progression of Parkinson disease into the development of potential novel therapies, and what role should neurologists and patients play in addressing this neurodegenerative condition?
Read More
Designing Multimedia Patient Education to Overcome COVID-19 Vaccine Hesitancy
March 23rd 2021How can health care systems talk about the issue of COVID-19 vaccine hesitancy with their patients? On this episode of Managed Care Cast, Pat Salber, MD, MBA, of The Doctor Weighs In, interviews the developer of interactive, people-centered, multimedia, educational programs for Wolters Kluwer Health.
Listen
Implications of Value-Based Care, Fee-for-Service Reimbursement Models Amid COVID-19
March 21st 2021Amid the pandemic, organizations utilizing a value-based care reimbursement model may be better positioned than those using a fee-for-service model to delineate high-risk patients and manage their care, particularly for long-term symptoms that may arise due to COVID-19.
Watch
Reasons for COVID-19 Vaccine Hesitancy in Patients With Blood Cancer Are Complex
March 19th 2021A survey released this month of US patients with blood cancers shows a somewhat surprising level of hesitancy about receiving a COVID-19 vaccine, but because patients with cancer were not included in clinical trials, the situation for this population is somewhat nuanced.
Read More
Shifting Dialysis Away From Employer-Based Coverage Cost Medicare $3 Billion, Study Finds
March 18th 2021The study examined the cost to Medicare when patients with end-stage renal disease switched from their employer-based health insurance to Medicare between 2007 and 2017 before the end of the 30-month coordination period.
Read More
Patients With PAH Have Similar Incidence of COVID-19, but Potentially Worse Outcomes
March 18th 2021Patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension had similar incidence of COVID-19, but the impact on clinical operations at the centers that treat these patients was substantial.
Read More
Infection Risk, Medical Claims High Among Patients With Multiple Sclerosis
March 17th 2021Patients with multiple sclerosis have high rates of urinary and kidney infections, inpatient hospitalizations, and outpatient hospital claims, according to recent results presented at the Americas Committee for Treatment and Research in Multiple Sclerosis annual meeting.
Read More
VBID Can Be a Tool to Address Health Care Affordability Concerns of Consumers
March 17th 2021A panel of experts provided consumer insights into value-based insurance design (VBID) and how the COVID-19 pandemic may have changed consumer behaviors in a way that VBID may be able to address as the country emerges from the pandemic.
Read More